A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease

Clinical trial NCT02453061 · COMPLETED

Trial details

NCT number: NCT02453061
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Huntington Disease

Start date: 2015-06-29
Primary completion: 2019-12-03
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.